Subcutaneous injections as a risk factor of myositis ossificans traumatica in spinal cord injury

International Journal of Rehabilitation Research

Volumn 30, Issue 1, 2007, Pages 87-90

  Gunduz, Berrin ^a,b   Erhan, Belgin ^a   Demir, Yaprak ^a  

^a MINISTRY OF HEALTH   (Turkey)

^b NONE   (Turkey)

Author keywords

Myositis ossificans traumatica; Spinal cord injury; Subcutaneous injection

Indexed keywords

BONE; DIAGNOSIS; MOLECULAR WEIGHT; MUSCLE; PATHOLOGY; PATIENT TREATMENT; PROTEINS;

HEPARIN; MYOSITIS OSSIFICANS TRAUMATICA; SPINAL CORD; SUBCUTANEOUS INJECTION;

DISEASES;

ETIDRONIC ACID; ICE; LOW MOLECULAR WEIGHT HEPARIN;

AGED; ARTICLE; CASE REPORT; CRYOTHERAPY; DEEP VEIN THROMBOSIS; ERYTHEMA; HUMAN; LEG SWELLING; MALE; OSSIFYING MYOSITIS; PARAPLEGIA; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; RISK FACTOR; SPINAL CORD INJURY;

AGED; ALKALINE PHOSPHATASE; ANTICOAGULANTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MYOSITIS OSSIFICANS; PARAPLEGIA; RISK FACTORS; SPINAL CORD INJURIES; VENOUS THROMBOSIS;

EID: 33846953251     PISSN: 03425282     EISSN: None     Source Type: Journal    
DOI: 10.1097/MRR.0b013e3280146f85     Document Type: Article

References (14)

1. Baysal T, Baysal O, Sarac K, Elmali N, Kutlu R, Ersoy Y (1999). Cervical myositis ossificans traumatica: a rare location. Eur Radiol 9:662-664.
2. Bodley R, Jamous A, Short D (1993). Ultrasound in early diagnosis of heterotopic ossification in patients with spinal injuries. Paraplegia 31:500-506.
3. Casazza BA, Young JL, Rossner KK (2000). Musculoskeletal disorders of the lower limbs. In: Braddom MD, Randall L, editors. Physical medicine and rehabilitation. Philadelphia: Saunders. pp. 818-852.
4. Frost FS (2000). Spinal cord injury medicine. In: Braddom MD, Randall L, editors. Physical medicine and rehabilitation. Philadelphia: Saunders. pp. 1230-1282.
5. Goldstein B (2000). Musculoskeletal conditions after spinal cord injury. Phys Med Rehabil Clin N Am 11:91-108.
6. Kaminsky SL, Corcoran D, Chubb WF, Pulla RJ (1992). Myositis ossificans: pedal manifestations. J Foot Surg 31:173-181.
7. Kirshblum S (2005). Rehabilitation of spinal cord injury. In: DeLisa JA, Gans B, editors. Rehabilitation medicine practice and principles. 4th ed. Philadelphia: Lippincott Williams & Wilkins. pp. 1715-1751.
8. Lal S, Hamilton BB, Heinemann A, Betts HB (1989). Risk factors for heterotopic ossification in spinal cord injury. Arch Phys Med Rehabil 70:387-390.
9. Mevio E, Rizzi L, Bernasconi G (2001). Myositis ossificans traumatica of the temporal muscle: a case report. Auris Nasus Larynx 28:345-347.
10. Reid DC (1992). Soft tissue injuries of the thigh. In: Sports injury assessment and Rehabilitation. Philadelphia: Churchill Livingstone. pp. 551-600.
11. Schurch B, Capaul M, Vallotton MB, Rossier AB (1997). Prostaglandin E2 measurements: their value in the early diagnosis of heterotopic ossification in spinal cord injury patients. Arch Phys Med Rehabil 78:687-691.
12. Steiner M, Gould AR, Kushner GM, Lutchka B, Flint R (1997). Myositis ossificans traumatica of the masseter muscle: review of the literature and report of two additional cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84:703-707.
13. Varghese G (1992). Heterotopic ossification. Phys Med Rehabil Clin N Am 3:407-415.
14. Wieder DL (1992). Treatment of myositis ossificans with acetic acid iontophoresis. Phys Ther 72:133-137.